Treatment for hamartoma tumors depends on the location they grow in and any harmful symptoms they cause. In many cases, hamartomas cause no side effects and treatment is unnecessary.

PTEN Research Foundation, a charity which funds and facilitates research with the aim of developing new and better treatments for PTEN Hamartoma Tumou. Rare Disease PTEN Hamartoma Tumour Syndrome ...

Nevus of Ota is a bluish or brownish pigment around or inside the eye. Learn more about what causes it, symptoms, and treatment options for this condition.

Iacobas I, Burrows PE, Adams DM, Sutton VR, Hollier LH, Chintagumpala MM . Oral rapamycin in the treatment of patients with hamartoma syndromes and PTEN mutation. Pediatr Blood Cancer 2011;57:321–3.

Successful treatment of hyperphagia by resection of a hypothalamic hamartoma. Case Report. Journal of Neurosurgery: Pediatrics , published online, ahead of print, April 9, 2013; DOI: 10.3171/2013. ...

More information: Sandra D. Castillo et al, Somatic uniparental disomy of PTEN in endothelial cells causes vascular malformations in patients with PTEN Hamartoma Tumor Syndrome, Cancer Discovery ...

A mesenteric lymphoid hamartoma was found in a 16-year-old boy associated with growth arrest, chronic hypochromic anemia and hypergammaglobulinemia. Radioisotope tracer scanning technics revealed t ...

Did you know that certain medications can cause symptom of 'Hamartoma'. Find these drugs listed on the page and be warned of similar symptoms as possible side-effects.

A hamartoma is a benign growth composed of an abnormal mixture of epithelial and mesenchymal elements. It is a part of any tissue that either grows faster or without the usual organization of its ...

Successful treatment of hyperphagia by resection of a hypothalamic hamartoma. Journal of Neurosurgery: Pediatrics , 2013; 1 DOI: 10.3171/2013.2.PEDS12552 Cite This Page : ...

A new study on the genetic causes of the PTEN Hamartoma Tumour Syndrome (PHTS) ... 2020 — One of the largest problems with cancer treatment is the development of resistance to anticancer therapies.